Get started
Author

Paul J. Converse

Observed names: Converse ,, Paul J, Converse, Paul J, J. Converse, Paul, P Converse, P J CONVERSE, P J Converse, P. CONVERSE, P. J. CONVERSE, P. J. Converse, P.J. Converse, Paul Converse, Paul J Converse, Paul Jerome Converse, Paul J. Converse
Observed institutions: Johns Hopkins University, Durham University, Johns Hopkins Medicine, All Africa Leprosy Tuberculosis and Rehabilitation Training Centre, Karolinska Institutet, Johns Hopkins Hospital, CSL (Australia), Armauer Hansen Research Institute, Rockefeller University, University of Gothenburg
ORCID: 0000-0002-1256-7464
Observed ORCID: 0000-0002-1256-7464
OpenAlex ID: A5027121657
Studies of a Ring-Cleaving Dioxygenase Illuminate the Role of Cholesterol Metabolism in the Pathogenesis of Mycobacterium tuberculosis
2009 · Katherine C. Yam, Igor D'Angelo, et al. · PLoS Pathogens · 226
PDF
Selective Killing of Nonreplicating Mycobacteria
2008 · Ruslana Bryk, Benjamin Gold, et al. · Cell Host & Microbe · 183
PDF
Role of the dosR - dosS Two-Component Regulatory System in Mycobacterium tuberculosis Virulence in Three Animal Models
2008 · Paul J. Converse, Petros C. Karakousis, et al. · Infection and Immunity · 152
Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli
1996 · P J Converse, A M Dannenberg, et al. · Infection and Immunity · 142
Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set
2004 · Ronggai Sun, Paul J. Converse, et al. · Molecular Microbiology · 137
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis
2015 · Rokeya Tasneen, Fabrice Betoudji, et al. · Antimicrobial Agents and Chemotherapy · 136
PDF
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
2015 · Sandeep Tyagi, Nicole C. Ammerman, et al. · Proceedings of the National Academy of Sciences · 124
Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice
2013 · Jacques H. Grosset, Sandeep Tyagi, et al. · American Journal of Respiratory and Critical Care Medicine · 115
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
1989 · G Kaplan, R Kiessling, et al. · The Journal of Experimental Medicine · 105
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
2019 · Jian Xu, Si-Yang Li, et al. · Antimicrobial Agents and Chemotherapy · 104
PDF
Attenuation of Late-Stage Disease in Mice Infected bythe Mycobacterium tuberculosis Mutant Lacking theSigF Alternate Sigma Factor and Identification ofSigF-Dependent Genes by MicroarrayAnalysis
2004 · Deborah E. Geiman, Deepak Kaushal, et al. · Infection and Immunity · 100
An in Vitro Predictive Test for Graft versus Host Disease in Patients with Genotypic HLA-Identical Bone Marrow Transplants
1985 · Georgia B. Vogelsang, Allan D. Hess, et al. · New England Journal of Medicine · 97
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
2017 · Si-Yang Li, Rokeya Tasneen, et al. · Antimicrobial Agents and Chemotherapy · 93
PDF
Mycobacterial‐induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients
1990 · Birhane Kaleab, Tom Ottenoff, et al. · European Journal of Immunology · 88
Comparison of a Tuberculin Interferon‐γ Assay with the Tuberculin Skin Test in High‐Risk Adults: Effect of Human Immunodeficiency Virus Infection
1997 · Paul J. Converse, Stephen L. Jones, et al. · The Journal of Infectious Diseases · 83
Deletionof Mycobacterium tuberculosis Sigma Factor E Results inDelayed Time to Death with Bacterial Persistence in the Lungsof Aerosol-InfectedMice
2003 · Masaru Ando, Tetsuyuki Yoshimatsu, et al. · Infection and Immunity · 73
Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations
2015 · Claire Andréjak, Deepak V. Almeida, et al. · Antimicrobial Agents and Chemotherapy · 72
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
2011 · Paul J Converse, Eric L Nuermberger, et al. · Future Microbiology · 71
Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9
2016 · Alvaro A. Ordonez, Rokeya Tasneen, et al. · Disease Models & Mechanisms · 64
Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice
2011 · Ming Zhang, Si-Yang Li, et al. · American Journal of Respiratory and Critical Care Medicine · 61
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment
2022 · Eric L. Nuermberger, Maria Santos Martínez-Martínez, et al. · Antimicrobial Agents and Chemotherapy · 60
PDF
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
2023 · Si-Yang Li, Paul J. Converse, et al. · Antimicrobial Agents and Chemotherapy · 59
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
2021 · Jian Xu, Paul J. Converse, et al. · Antimicrobial Agents and Chemotherapy · 56
Pulmonary Bovine-Type Tuberculosis in Rabbits: Bacillary Virulence, Inhaled Dose Effects, Tuberculin Sensitivity, andMycobacterium vaccaeImmunotherapy
1998 · P. J. Converse, A. M. Dannenberg, et al. · Clinical and Diagnostic Laboratory Immunology · 54
BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse
2011 · Paul J. Converse, Deepak V. Almeida, et al. · PLoS neglected tropical diseases · 53
PDF
Works count: 107
Citation count: 3,761
H-index: 36
I10-index: 68
Year
Topic
Type